Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (41)
Daniel L. Cohen, Shiran Nakash, Anton Bermont, Vered Richter & Haim Shirin. (2023) Predictors of Underlying Esophageal Motility Disorders in Patients Presenting with Esophageal Candidiasis. Southern Medical Journal 116:8, pages 701-706.
Crossref
Crossref
Natalie Patel, Prasenjit Das & Dhanpat Jain. 2022. Surgical Pathology of the Gastrointestinal System. Surgical Pathology of the Gastrointestinal System
521
572
.
Julián E. Barahona-Correa, Alejandro De la Hoz, María José López, Javier Garzón, Yannick Allanore & Gerardo Quintana-López. (2020) Infecciones y esclerosis sistémica: un desafío emergente. Revista Colombiana de Reumatología 27, pages 62-84.
Crossref
Crossref
Julián E. Barahona-Correa, Alejandro De la Hoz, María José López, Javier Garzón, Yannick Allanore & Gerardo Quintana-López. (2020) Infections and systemic sclerosis: an emerging challenge. Revista Colombiana de Reumatología (English Edition) 27, pages 62-84.
Crossref
Crossref
Martinsen, Fossmark & Waldum. (2019) The Phylogeny and Biological Function of Gastric Juice—Microbiological Consequences of Removing Gastric Acid. International Journal of Molecular Sciences 20:23, pages 6031.
Crossref
Crossref
Ana Petcu, Linda Ghib, Simona Grad, Cornelia Popovici, Liliana Rogojan, Nicolae Rednic & Simona Rednic. (2019) Upper gastrointestinal involvement in systemic sclerosis: Findings in a real‑life setting. Experimental and Therapeutic Medicine.
Crossref
Crossref
Leon Fisher & Alexander Fisher. (2017) Acid-Suppressive Therapy and Risk of Infections: Pros and Cons. Clinical Drug Investigation 37:7, pages 587-624.
Crossref
Crossref
H. W. Daniell. (2016)
Acid suppressing therapy as a risk factor for
C
andida
esophagitis
. Diseases of the Esophagus 29:5, pages 479-483.
Crossref
Crossref
Vikneswaran Namasivayam & Joseph A. Murray. 2013. Principles of Deglutition. Principles of Deglutition
657
670
.
Ghaith Noaiseh, Sophia Li & Chris T Derk. (2012) Management of gastrointestinal manifestations in systemic sclerosis (scleroderma). International Journal of Clinical Rheumatology 7:6, pages 661-673.
Crossref
Crossref
Pamela A. Morganroth, Victoria P. Werth & David A. Katzka. 2012. The Esophagus. The Esophagus
763
781
.
Siva Doma, John M. Wo & Henry P. Parkman. 2012. The Esophagus. The Esophagus
367
382
.
David A. Katzka. 2010. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Sleisenger and Fordtran's Gastrointestinal and Liver Disease
735
743.e4
.
D Khanna & E Melikterminas. (2008) Gastrointestinal involvement in systemic sclerosis. Indian Journal of Rheumatology 3:1, pages 13-20.
Crossref
Crossref
Namal Weerasuriya & Jeremy Snape. (2008) Oesophageal Candidiasis in Elderly Patients. Drugs & Aging 25:2, pages 119-130.
Crossref
Crossref
Dinesh Khanna. 2008. Digestive Involvement in Systemic Autoimmune Diseases. Digestive Involvement in Systemic Autoimmune Diseases
51
61
.
I. MARIE, P. DUCROTTE, P. DENIS, M. F. HELLOT & H. LEVESQUE. (2006) Oesophageal mucosal involvement in patients with systemic sclerosis receiving proton pump inhibitor therapy. Alimentary Pharmacology and Therapeutics 24:11-12, pages 1593-1601.
Crossref
Crossref
Stavros K. Ntoumazios, Paraskevi V. Voulgari, Konstantinos Potsis, Evagelos Koutis, Niki Tsifetaki & Dimitrios A. Assimakopoulos. (2006) Esophageal Involvement in Scleroderma: Gastroesophageal Reflux, the Common Problem. Seminars in Arthritis and Rheumatism 36:3, pages 173-181.
Crossref
Crossref
Isabelle Marie. (2006) Atteinte digestive au cours de la sclérodermie systémique. La Presse Médicale 35:12, pages 1952-1965.
Crossref
Crossref
Ellen C. Ebert. (2006) Esophageal Disease in Scleroderma. Journal of Clinical Gastroenterology 40:9, pages 769-775.
Crossref
Crossref
Savio Reddymasu, Fathali Borhan-Manesh & Paul A. Jordan. (2006) Spontaneous Pneumomediastinum due to Achalasia: A Case Report. Southern Medical Journal 99:8, pages 892-893.
Crossref
Crossref
Tom C. Martinsen, Kare Bergh & Helge L. Waldum. (2005) Gastric Juice: A Barrier Against Infectious Diseases. Basic <html_ent glyph="@amp;" ascii="&"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&"/> Toxicology 96:2, pages 94-102.
Crossref
Crossref
Reza Shaker & David Staff. (2001) ESOPHAGEAL DISORDERS IN THE ELDERLY. Gastroenterology Clinics of North America 30:2, pages 335-361.
Crossref
Crossref
Jayshree V. Ganatra, Howard E. Bostwick, Marvin S. Medow, Debra Beneck & Stuart Berezin. (1996) Candida Esophagitis in a Child with Achalasia. Journal of Pediatric Gastroenterology & Nutrition 22:3, pages 330-333.
Crossref
Crossref
Clarence W. LegertonIIIIII, Edwin A. Smith & Richard M. Silver. (1995) SYSTEMIC SCLEROSIS (SCLERODERMA). Rheumatic Disease Clinics of North America 21:1, pages 203-216.
Crossref
Crossref
J. LARNER & M. I. R. HAMILTON. (2007) Review article: infective complications of therapeutic gastric acid inhibition. Alimentary Pharmacology & Therapeutics 8:6, pages 579-584.
Crossref
Crossref
Robert W. Sjogren. (2005) Gastrointestinal motility disorders in scleroderma. Arthritis & Rheumatism 37:9, pages 1265-1282.
Crossref
Crossref
Aditya K. Gupta, Daniel N. Sauder & Neil H. Shear. (1994) Antifungal agents: An overview. Part II. Journal of the American Academy of Dermatology 30:6, pages 911-933.
Crossref
Crossref
I C Talbot. (1994) Tumor necrosis factor alpha in inflammatory bowel disease.. Gut 35:5, pages 715-715.
Crossref
Crossref
G Basilisco, R Barbera, M Molgora, M Vanoli & P A Bianchi. (1994) Reply. Gut 35:5, pages 714-715.
Crossref
Crossref
A J Larner. (1994) Oesophageal acid clearance.. Gut 35:5, pages 714-715.
Crossref
Crossref
H J F Hodgson & M Z Maslam. (1994) Reply. Gut 35:5, pages 714-714.
Crossref
Crossref
J Satsangi & D P Jewell. (1994) Cytokine production in inflammatory bowel disease.. Gut 35:5, pages 714-714.
Crossref
Crossref
André Kahan & Charles-Joel Menkés. (1994) Gastrointestinal involvement in systemic sclerosis. Clinics in Dermatology 12:2, pages 259-265.
Crossref
Crossref
Paul H. Baehr & George B. McDonald. (1994) Esophageal infections: Risk factors, presentation, diagnosis, and treatment. Gastroenterology 106:2, pages 509-532.
Crossref
Crossref
R. Lorenz, G. Jorysz & M. Classen. (1993) The value of endoscopy and endosonography in the diagnosis of the dysphagic patient. Dysphagia 8:2, pages 91-97.
Crossref
Crossref
Loren Laine, Robin H. Dretler, Chris N. Conteas, Carmelita Tuazon, Frederick M. Koster, Fred Sattler, Kathleen Squires & Muhammed Z. Islam. (1992) Fluconazole Compared with Ketoconazole for the Treatment of Candida Esophagitis in AIDS. Annals of Internal Medicine 117:8, pages 655-660.
Crossref
Crossref
L. HENDEL, E. HAGE, J. HENDEL & P. STENTOFT. (2007) Omeprazole in the long‐term treatment of severe gastro‐oesophageal reflux disease in patients with systemic sclerosis. Alimentary Pharmacology & Therapeutics 6:5, pages 565-577.
Crossref
Crossref
Henry M. Blumberg, Edward F. Hendershot & Timothy J. Lott. (1992) Persistence of the same Candida albicans strain despite fluconazole therapy. Diagnostic Microbiology and Infectious Disease 15:6, pages 545-547.
Crossref
Crossref
C.Mel Wilcox. (1992) Esophageal disease in the acquired immunodeficiency syndrome: Etiology, diagnosis, and management. The American Journal of Medicine 92:4, pages 412-421.
Crossref
Crossref
Sam R. Fulp & Donald O. Castell. (1990) Scleroderma esophagus. Dysphagia 5:4, pages 204-210.
Crossref
Crossref